🔎 Trials Near Me

Home › Lupus › Florida › Plantation

Pag-aaral pangklinika para sa Lupus sa Plantation, FL

Isang pag-aaral para sa Lupus ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Plantation. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Nagre-recruitPhase 3
  • Integral Rheumatology And Immunology Specialists, Plantation
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07438496

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Nagre-recruitPhase 1
  • Research Site, Plantation
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07201558

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Nagre-recruitPhase 2
  • Integral Rheumatology and Immunology Specialist, Plantation
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07409181

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Nagre-recruitPhase 3
  • Sl0044 50324, Plantation
Edad 16 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06617325

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Nagre-recruitPhase 3
  • IRIS Research and Development, Plantation
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT06133972

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

Nagre-recruitPhase 1
  • IRIS Research and Development, LLC, Plantation
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2024 · NCT06581562

Pag-aaral para sa Lupus sa ibang lungsod

Iba pang pag-aaral sa Plantation

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.